Building a Complete Ortho Pain Management Portfolio: A PCD Franchise Partner's Guide

A single strong product rarely builds a lasting PCD franchise business. What actually sustains a franchise partner long term is a portfolio broad enough to answer most of what an orthopedic prescriber sees in a typical week, without gaps that send that same doctor looking elsewhere for the rest.

Servochem's home page positions the company around exactly this idea, an established ortho and pain management range built for franchise partners who want to represent more than one product. This guide walks through how to actually think about building that portfolio, category by category, rather than picking whatever formulation happens to be pitched first.

Start With the Categories That Cover the Most Ground

Before adding niche formulations, a franchise partner's core portfolio should cover the conditions that come up most often in ortho and pain management practice.

• Anti-inflammatory and pain relief, covering both selective COX-2 inhibitors and extended-release NSAID options
• Joint support combinations, particularly for early-stage osteoarthritis management
• Hyperuricemia and gout management, a category with steady, recurring demand
• Bone health and Vitamin D support, relevant across ortho, general medicine, and gynecology referrals

These four categories alone cover a meaningful share of what a general orthopedic or pain management practice prescribes for regularly. A franchise partner who can speak to all four in one conversation with a prescriber is in a fundamentally different position than one representing a single isolated product.

What Belongs in Each Category

For anti-inflammatory and pain relief, Servochem's range includes the Koxitor line, a selective COX-2 inhibitor family, alongside Todoset 600, an extended-release Etodolac formulation built for sustained, once-daily management of chronic joint and inflammatory pain rather than acute flare-ups. Carrying both gives a franchise partner coverage across different prescriber preferences, since not every doctor defaults to the same NSAID class for every patient.

Joint support sits in a related but distinct category. Forjoint, combining Diacerein and Glucosamine Sulphate, and the Tendiser range address joint and connective tissue support specifically, often prescribed alongside rather than instead of an anti-inflammatory.

Hyperuricemia management is frequently overlooked by newer franchise partners building their first portfolio, despite being a consistent, recurring prescribing category. Buxofeb, a selective xanthine oxidase inhibitor, fills this gap without requiring a separate manufacturing relationship.

Bone health and Vitamin D support round out a core portfolio well, since this category sees demand well beyond orthopedic practice alone, into general medicine and gynecology referrals. The Ostovista range covers this ground with multiple strength and combination options.

Sequencing: What to Add First, and What Can Wait

A new franchise partner does not need every category on day one. A reasonable sequence looks like this:

1. Establish anti-inflammatory and pain relief coverage first, since this is what most prescribers expect to see immediately
2. Add joint support combinations once initial prescriber relationships are forming, as a natural follow-up conversation
3. Introduce hyperuricemia management as a distinct, separate offering rather than bundling it in from the start
4. Layer in bone health and nutraceutical support last, once the core prescribing relationship is established

This sequencing matters because introducing too many categories at once can dilute a franchise partner's initial pitch to a prescriber. A focused, well-explained core range builds credibility faster than an overwhelming full catalog presented all at once.

Why a Single Manufacturer Relationship Matters Here

Building this kind of portfolio across multiple manufacturers creates real friction that does not show up until months into a franchise business. Different dispatch schedules, different documentation standards, and different points of contact for each supplier add operational complexity that a growing franchise partner does not need.

Servochem manufactures its entire ortho and pain management range under one WHO-GMP certified process, which means a franchise partner building a portfolio across all four core categories is still working with a single order process, a single documentation standard, and a single point of accountability if something needs addressing.

Common Mistakes When Building a Portfolio

A few patterns show up repeatedly among franchise partners who struggle to grow their initial territory:

1. Representing multiple overlapping products within the same category instead of genuine category breadth
2. Adding a new category before the previous one has real traction with prescribers
3. Choosing products based on margin alone rather than whether prescribers actually reach for that specific formulation
4. Underestimating how much consistent supply matters once a prescriber starts recommending a product regularly

Avoiding these patterns matters more than chasing the widest possible catalog. A focused, well-supported portfolio outperforms a broad but shallow one almost every time.

What This Looks Like for an Existing Franchise Partner

For partners already representing part of Servochem's range, the same logic applies to expansion. Rather than adding whatever new product is announced next, it is worth mapping current territory prescribing patterns against the four core categories and identifying the genuine gap. A partner already strong in anti-inflammatory and pain relief but missing bone health coverage is leaving a specific, identifiable slice of prescriber demand unaddressed, one that a nearby competitor's franchise partner is likely already filling. Reviewing this gap periodically, rather than only when a new product launch prompts the conversation, tends to produce steadier territory growth than reactive expansion. This kind of periodic review is worth building into a regular quarterly habit, rather than treating portfolio expansion as a one-time decision made at the start of a franchise partnership and never revisited again as prescriber relationships and territory demand naturally shift over time. A franchise partner who treats this as an ongoing process, rather than a decision made once and forgotten, generally ends up with a more resilient territory over time. It also makes conversations with Servochem's team more productive, since a partner arriving with a specific, identified gap gets a more useful recommendation than one asking generally what else is available.

Getting Started

Whether you are building your first ortho portfolio or expanding an existing franchise territory, Servochem's home page is the starting point for reviewing the full range, and the enquiry process confirms pricing, area availability, and franchise terms directly.

Frequently Asked Questions

What products should a first-time ortho PCD franchise portfolio include?

Start with anti-inflammatory coverage like Koxitor or Todoset 600, then add joint support and hyperuricemia management as prescriber relationships grow.

Is Todoset 600 suitable for daily long-term ortho pain management?

Yes. Todoset 600 is an extended-release Etodolac formulation built for sustained, once-daily use in chronic joint and inflammatory pain, not acute flare-ups.

How many product categories should a new franchise partner start with?

Two to three core categories is usually enough initially, expanding once prescriber relationships in the first category are established.

Does Servochem manufacture its full ortho range under one facility?

Yes. The entire ortho and pain management range is manufactured under one WHO-GMP certified process from a single Panchkula facility.

What is the most commonly overlooked category in an ortho PCD franchise portfolio?

Hyperuricemia and gout management is frequently added too late, despite being a consistent, recurring prescribing category.

How do I get pricing for building a full ortho portfolio with Servochem?

Submit an enquiry through Servochem's home page, specifying which categories you want to start with and your target operating area.